NCT03724552 - Photobiomodulation in Autism Spectrum Disorder (ASD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 13, 2017

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions

AutismAutism Spectrum Disorder

Interventions

DEVICE

Transcranial LED Therapy (Participants ages 9-17)

Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention in which near-infrared light (830nm-850nm) is applied to forebrain.

DEVICE

Transcranial LED Therapy (Participants ages 18-59)

Transcranial Laser Emitting Diode (LED) Therapy (TLT) is a noninvasive intervention in which near-infrared light (830nm-850nm) is applied to forebrain.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER